US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist

2.340
0.0000.00%

Close Jul 2 16:00 ET

2.370
+0.030+1.28%

Post 19:26 ET

443.34MMarket Cap-2600P/E (TTM)

Esperion Therapeutics Stock Forum

Stock Region

Jun 28 17:03

Biopharmaceutical Company Announces Enters Into Major Financial Transaction With Life Sciences Giant

Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility.
Esperion, a well-known entity in the biopharmaceutical industry trading under the Nasdaq symbol ESPR, has recently entered into a pivotal financial transaction with OMERS Life Sciences, a prominent investor in the life sciences sector. The essence of this transaction r...

Trytosaveabit

Jun 28 06:50

Looking good so far

$Esperion Therapeutics(ESPR.US)$

Trytosaveabit

Jun 28 06:08

Update

$Esperion Therapeutics(ESPR.US)$ Reuters· 5 mins. Omers Life Sciences to Purchase Esperion's European Royalty on Bempedoic Acid Products for $304.7 Mln

Mr Long Term

Jun 22 21:57

ColumnsWall Street's Top 10 Call This Week.

Wall Street experts reveal the five stocks to buy, five stocks to sell this week
What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street's best analysts during the week of June 17-21.
Top 5 Buy Calls:
1. Skyworks upgraded to Buy at B. Riley
$Skyworks Solutions(SWKS.US)$
B. Riley upgraded Skyworks (SWKS) to Buy from Neutral with a price target of $130, up from $96, ahead of the July 8 through 11 SEM...

hasrimoovice

Jun 10 10:02

looking good on daily TF

$Esperion Therapeutics(ESPR.US)$ looking at Daily timeframe it is doing ok. recently EMA50 crossup EMA200 which is good indicate a change of trend to uptrend.. will monitor and definitely going into my WL

ProperMicheleV

May 29 12:28

Down

I hate these days. I know it's investing & I'm long with my bets, but I have better, more exciting days when I don't see a lot of red. Sucks. And, I was terminated from my job in April & having a hard time getting unemployment. I was a 1099 contractor on that job & the department of labor doesn't know how to process my claim. This is making me low on hard cash & I'm going to have to sell a position or 2, and I DO NOT WANT TO DO THAT, especially with $Esperion Therapeutics (ESPR.US)$. I read...

life is a blessing

May 29 00:29

Esperion Therapeutics Is Now A Top Choice Takeover Target

$Esperion Therapeutics(ESPR.US)$ Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, have positioned it as defininte acquistion target for larger pharmaceutical companies. Esperion's drugs NEXLIZET and NEXLETOL now have primary prevention labels, NEXLIZET will soon become the drug of choice over a PCSK9 inhibitor says Texas based HeartPlace leading Cardio...

Jaguar8

May 22 08:51

$Esperion Therapeutics(ESPR.US)$
NEWS
First-In-Class Cholesterol-Lowering Treatment NILEMDO® (NEXLETOL® in the U.S.) and Its Combination with Ezetimibe, NUSTENDI® (NEXLIZET® in the U.S.), Approved In Europe To Treat Hypercholesterolemia and Significantly Reduce Cardiovascular Risk
The European Commission has approved label updates for NILEMDO (bempedoic acid) and NUSTENDI (bempedoic acid/ezetimibe) to treat hypercholesterolemia and reduce cardiovascular risk. This approval is based on the positi...

Be a voice no echo

May 22 07:10

obviously

$Esperion Therapeutics(ESPR.US)$

Trytosaveabit

May 22 07:02

News

$Esperion Therapeutics(ESPR.US)$ Esperion Therapeutics Inc: European Commission Approved Label Update of Both Nilemdo and Nustendi

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall